NEWS

WIRES

OTHER

Andersen Jones Lands New Breast Cancer Clients

The agency was recently selected by Agendia in Irvine to launch their Symphony Breast Cancer Decision System. Symphony is a unique molecular diagnostics tool available to breast surgeons and medical oncologists. The system helps physicians address complex treatment decisions by screening the patient's genetic profile against all the known genes that affect breast cancer. The result quantifies the potential for breast cancer recurrence in that patient, providing the physician with critical information for determining the best course of treatment for the patient.

San Diego-based ImpediMed is the world leader in the development and distribution of medical devices utilizing bioimpedance spectroscopy for use as an aid in noninvasive clinical assessment of lymphedema. ImpediMed recently hired Andersen Jones to develop expanded branding strategies for their L-Dex system. In a recent Washington Post story, lymphedema was called "breast cancer's dirty little secret." Women who undergo mastectomy or axilliary node dissection are at risk for developing the condition which presents as a severe swelling of the limb where lymph nodes have been removed. The L-Dex system is a simple, noninvasive test that women can have every 90 days in a follow-up visit with their breast surgeon.

Andersen Jones has a long track record in women's health starting with their pioneering work with Biopsys to commercialize the Mammotome stereotactic breast biopsy system. According to agency President Rick Andersen, "Our new assignments with Agendia and ImpediMed build on our experience in the breast cancer space with innovative technologies that give the physician new personalized medicine alternatives."

Headquartered in San Juan Capistrano, Andersen Jones has been one of the leading independent advertising agencies specializing in medical devices and diagnostics since 1985. To learn more, contact Rick Andersen at 949-240-6802 or rick@andersenjones.com.

For Andersen Jones Marketing Medicine
Paul Williams, 949-916-6880
medialine2@aol.com